Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.1386-3.38%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.42% | -12.64% | -9.38% | -6.63% | -2.34% |
| Total Other Revenue | 33.76% | 33.76% | 8.70% | 40.21% | 10.82% |
| Total Revenue | -10.82% | -12.05% | -9.17% | -6.11% | -2.19% |
| Cost of Revenue | -2.09% | -5.49% | -5.35% | -3.92% | 0.68% |
| Gross Profit | -25.00% | -22.49% | -14.96% | -9.42% | -6.51% |
| SG&A Expenses | 10.79% | 9.42% | -0.24% | 4.79% | 0.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 144.29% | 14.67% | 39.02% | 38.06% | -23.16% |
| Total Operating Expenses | -0.25% | -3.36% | -4.56% | -2.32% | 0.75% |
| Operating Income | -47.76% | -41.30% | -24.14% | -17.89% | -11.23% |
| Income Before Tax | -80.19% | -73.83% | -57.32% | -43.78% | -17.02% |
| Income Tax Expenses | -39.14% | -37.16% | -36.94% | -21.20% | 6.13% |
| Earnings from Continuing Operations | -87.24% | -79.58% | -60.27% | -47.05% | -20.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 144.17% | 65.51% | 72.85% | -3.86% | 7.53% |
| Net Income | -80.49% | -80.43% | -58.94% | -50.69% | -21.27% |
| EBIT | -47.76% | -41.30% | -24.14% | -17.89% | -11.23% |
| EBITDA | -41.82% | -36.36% | -20.86% | -15.18% | -9.14% |
| EPS Basic | -80.66% | -80.63% | -58.84% | -50.94% | -21.62% |
| Normalized Basic EPS | -36.92% | -45.84% | -7.77% | -15.50% | 1.23% |
| EPS Diluted | -80.65% | -80.62% | -58.89% | -50.99% | -21.68% |
| Normalized Diluted EPS | -36.92% | -45.84% | -7.72% | -15.45% | 1.29% |
| Average Basic Shares Outstanding | -0.48% | -0.22% | -0.34% | 0.25% | 0.38% |
| Average Diluted Shares Outstanding | -0.48% | -0.22% | -0.44% | 0.15% | 0.28% |
| Dividend Per Share | -47.01% | -47.01% | 1.68% | 1.68% | 1.68% |
| Payout Ratio | 4.72% | 4.60% | 1.53% | 10.72% | 0.28% |